People · Operator

Douglas Eckert

Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals

1
Companies
1
Filings
$8.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Slate Pharmaceuticals, Inc.PharmaceuticalsSeed$8.4M$75.7M2009
Operator network

Douglas Eckert at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Anthony Wild · 3 companies · 1 sharedAnthony WildMIchael Ford · 3 companies · 1 sharedMIchael FordTrygve Mikkelsen · 3 companies · 1 sharedTrygve MikkelsenAnthony Robert Wild · 2 companies · 1 sharedAnthony Robert Wi…Richard Robert DeSchutter · 2 companies · 1 sharedRichard Robert De…Trygve Robert Mikkelsen · 2 companies · 1 sharedTrygve Robert Mik…Douglas Stanley Eckert · 1 companies · 1 sharedDouglas Stanley E…Kenneth Ramsey Couch · 1 companies · 1 sharedKenneth Ramsey Co…Michael Stanley Ford · 1 companies · 1 sharedMichael Stanley F…Richard DeSchutter · 1 companies · 1 sharedRichard DeSchutterRobert Stanley Whitehead · 1 companies · 1 sharedRobert Stanley Wh…William Robert Dahl · 1 companies · 1 sharedWilliam Robert Da…Slate Pharmaceuticals, Inc. · $8.4M raisedSlate Pharmaceuticals…Douglas EckertDE
Douglas Eckert Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Douglas Eckert on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Anthony Wild13
MIchael Ford13
Trygve Mikkelsen13
Anthony Robert Wild12
Richard Robert DeSchutter12
Trygve Robert Mikkelsen12
Richard DeSchutter11
Kenneth Ramsey Couch11
Douglas Stanley Eckert11
Michael Stanley Ford11
Robert Stanley Whitehead11
William Robert Dahl11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.